Case 45

AI Pathology

This company develops artificial intelligence software for cancer diagnosis and digital pathology image analysis to support pathologists and laboratories.

Spotlight Medical

This company develops AI-driven prognosis tests to help oncologists select the most effective treatments for cancer patients.

Health Triage

This company develops artificial intelligence software for early cancer detection and clinical diagnosis to assist healthcare facilities and medical professionals.

Artera

This company develops artificial intelligence tests that predict cancer outcomes and treatment benefits for clinicians and their patients.

StratifAI

This company develops multimodal artificial intelligence biomarkers to predict cancer recurrence risks from pathology slides for oncologists and pharmaceutical organisations.

Omica

This company develops artificial intelligence software to screen pathology slides for cancer biomarkers, serving hospital laboratories and biopharmaceutical partners to improve patient therapy selection.

Ataraxis AI

This company develops artificial intelligence models that predict cancer outcomes and treatment responses for healthcare providers and oncologists.

Digistain

This company develops a diagnostic test using infrared spectroscopy to provide breast cancer recurrence-risk stratification for oncologists and multidisciplinary clinical teams.